PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
about
Retroviral oncogenes: a historical primerGenetic instability in the tumor microenvironment: a new look at an old neighborCellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorDiscovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946)The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.Stress responses from the endoplasmic reticulum in cancerPTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastomaCaveolin-1 regulates endothelial adhesion of lung cancer cells via reactive oxygen species-dependent mechanismSustained proliferation in cancer: Mechanisms and novel therapeutic targetsKnockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C ReleaseThe Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT.Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.DNA damage signaling guards against perturbation of cyclin D1 expression triggered by low-dose long-term fractionated radiationRelationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.The drosophila T-box transcription factor midline functions within Insulin/Akt and c-Jun-N terminal kinase stress-reactive signaling pathways to regulate interommatial bristle formation and cell survival.Nonovarian origins of ovarian cancer.PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinomaPTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injuryInitial testing (stage 1) of the phosphatidylinositol 3' kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program.Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.Mitochondrial reactive oxygen species perturb AKT/cyclin D1 cell cycle signaling via oxidative inactivation of PP2A in lowdose irradiated human fibroblasts.SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cellsCell survival and metastasis regulation by Akt signaling in colorectal cancerHepatocyte polarityNutrient restriction enhances the proliferative potential of cells lacking the tumor suppressor PTEN in mitotic tissuesGenes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.Effects of a brief high-fat diet and acute exercise on the mTORC1 and IKK/NF-κB pathways in rat skeletal muscleEpigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway.PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.Biochemistry and structure of phosphoinositide phosphatases.
P2860
Q24611142-93D33F97-B7AD-406D-B3F1-C86C0C5E3127Q26801374-99E92159-6076-41FB-93BB-585BA77D4904Q26863333-DD3429EB-E869-4E75-846A-A9460734E0EEQ27711042-7C2BA7CB-4B66-4570-B94F-8FC6333FD24CQ27852562-523FDDCB-523E-40DD-910C-A35749AD343AQ28082709-516A2AE5-E15C-497D-BB4E-CBE5D9180F78Q28115966-460762B4-A93C-4B28-B21B-EBF4AC25AE7AQ28394957-F54B76E1-19EC-4B50-910A-20D41B803717Q28396388-794A527A-041C-4041-85DC-84C1DD5401A3Q28550350-642ABF9B-519B-49D1-914C-16C755935F2BQ30009944-137563C1-7035-4B3E-86F8-CE8EA887D7A2Q33744196-35B5D5BA-16F6-48B0-910A-B2B4CBAD6979Q33926034-0CBB4E6A-6439-4D32-AA31-5054C0C8ED95Q34260622-4C02226B-D5AF-46CA-BA3B-7F4BB3CB1DEDQ34310319-6B8B84BB-8F08-4307-879B-72E863B0FDE7Q34729935-93DD3CED-F2D6-43F1-B9BE-A3E53FA08613Q34766991-55ECC527-9433-4ACE-BCA4-A0C626FBBBB5Q35140496-32BCC5AB-E105-4AA3-A966-FE18FCD5BD53Q35728921-63C28F5E-5973-4A0D-B24D-6A30A3CD84A8Q35776145-719B2103-37DF-4BEF-87A8-29F7446B1885Q35845033-976AF143-CF50-4F64-B1B3-D299213B7C75Q36086862-D5C6FED5-9959-4914-B543-EBB914EF9B1DQ36211287-7C15B04C-7A6F-49C7-978A-E82DE3EA23EBQ36361068-C9776E90-C8D0-4566-A334-839B85F2ECBFQ36369980-B69C077B-B384-4C92-9FDE-FCF1F48FF20AQ36386881-972335FD-7B92-46D8-A702-4EC4020E4D0EQ36645354-A87B481B-5D2B-4FCE-B82A-895FB1314CE5Q36772197-4CEC8037-37AB-468A-BD7B-9340B95B8A12Q36808215-873347E0-3020-4F13-A7BD-82A53322BB01Q36938826-75421D33-3FDE-4E4B-8F4C-C16BCEA8F60AQ36972087-4603E7E1-70EC-4C09-A89A-28F82C1313B0Q36998767-2CB33E3C-39F8-487E-99FA-5A3EB8CD101BQ37035724-5767C189-A396-466E-8A0B-DC18E99E89F6Q37257953-A55464C3-559D-46F3-AA9F-C911CD98D978Q37260961-DF2F0445-B2F6-48B1-A73F-B7FD6C87BB4FQ37479693-17D89B7B-0265-41DB-B0C7-134A239D1D72Q37628937-EDD11D5A-6F68-4202-A8A5-FDB9996CE970Q37975246-E451E6F6-342D-4CF6-B52C-943E6EC81D74Q38021448-325DB2E3-16C4-4182-B0E8-A898B1299EB0Q38076803-2F7ACF01-BD89-4105-89FD-7C8D7A36FF53
P2860
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@ast
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@en
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@nl
type
label
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@ast
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@en
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@nl
prefLabel
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@ast
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@en
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@nl
P2860
P356
P1433
P1476
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
@en
P2093
Maria-Magdalena Georgescu
P2860
P304
P356
10.1177/1947601911407325
P577
2010-12-01T00:00:00Z